Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
NEW YORK (Reuters Health) – Combining hepatic artery infusion of floxuridine/dexamethasone with systemic oxaliplatin and irinotecan can make liver metastases from colorectal cancer resectable in about half of…
On April 22nd, 2009, people from around the globe gathered at US Cellular Field in Chicago to announce the Learning Living & Loving campaign. This call to action…
NEW YORK (Reuters Health) – Advanced prostate cancer appears to be of a more aggressive type when it occurs in young men, leading to dramatically higher cancer-specific mortality…
NEW YORK (Reuters Health) – In cancer patients accidentally overexposed with 5-fluorouracil (5-FU) chemotherapy, the investigational drug vistonuridine (Wellstat Therapeutics Corp) may be lifesaving, according to research to…
Kim Hunter-Schaedle, PhD, Chief Scientific Officer of the Children’s Tumor Foundation, discusses Neurofibromatosis, a complex disorder that affects 1 in 3000 children, making it more common than better…
NEW YORK (Reuters Health) – Contraception, or different reproductive patterns related to contraceptive methods, may affect the risk of some types of cancer, according to findings from the…
NEW YORK (Reuters Health) – Long-term adjuvant therapy with pegylated interferon alfa-2b (PEG-IFN-alpha-2b) for advanced melanoma improves recurrence-free survival, investigators report in an early online release from the…
NEW YORK (Reuters Health) – Using a new approach to detect tumor-associated plasma proteins, Canadian researchers have discovered a novel biomarker that may improve the diagnosis of lung…
Kim Hunter-Schaedle, PhD, Chief Scientific Officer of the Children’s Tumor Foundation, discusses the role of the CTF in education and research of neurofibromatosis, a disorder of tumor suppressors.…
NEW YORK (Reuters Health) Women with long-standing hypothyroidism are at increased risk of hepatocellular carcinoma, the results of a case-control study suggest. By contrast, hypothyroidism is not significantly…
